US challenges ‘bogus’ patents on Ozempic, other drugs in effort to spur competition
WASHINGTON — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that …